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The Iactogenic activity (LA.) of oPRL and hGH derivatives obtained by chemical rn~i~~tions of lysine 
residues was studied by radioreceptor assay. Control treatment with borohydride had a slight effect on the 
L.A. of hGH but drasticaily reduced the oPRL activity; this latter was preserved in the presence of iodoacet- 
amide. Methylation, ethylation, guanidination and acetimidination affected the L.A. of both hormones as 
a function of the degree of modification. The structure-binding relationships to the lactogenic receptors are 
discussed, suggesting that the lysine or arginine residues in homologous positions 42, 51, 73, 128, 146 of 
oPRL and 47,50, 73, 128, 147 of hGH might be particularly involved. 
Prolactin Growth hormone Lysine residue Receptor Structure 
1. INTRODUCTION 
Ovine prolactin (oPRL) and human growth hor- 
mone (hGH) belong to 2 families of polypeptides 
with closely related structures probably evolved 
from a common ancestral short peptide [ 11. A con- 
siderable number of amino acids has been pre- 
served during evolution. A hypothetical molecular 
model of an archetype of the superfamily compris- 
ing prolactins, growth hormones and placental ac- 
togens has even been proposed [2]. As regards their 
genetic origin, we know that hGH and oPRL are 
encoded by genes located on different 
chromosomes [3]. During phylogenetic evolution 
some of these molecules, such as hGH or ovine 
chorionic somatomammotropin (oCS), preserved 
both their lactogenic and growth-promoting ac- 
tivities. Other molecules, such as prolactin or 
human placental lactogen, only exhibit lactogenic 
activity. Moreover some others, such as bovine 
GH (bGH), only act as growth-promoting hor- 
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mones. The close structural relationship between 
proteins exhibiting a lactogenic activity suggests 
that certain sequences and a common 
topqgraphical arrangement are involved in the in- 
teraction of these hormones with their specific 
receptors and in the induction of the activity. 
We have previously investigated whether lysine 
residues were involved in the binding of the oCS 
molecule to lactogenic and somatotropic receptors 
141. Here, we studied the effects of some chemical 
modifications of lysine residues of 2 lactogenic 
hormones (oPRL and hGH) on the binding to lac- 
togenic receptors. The examined hormones have 9 
lysine residues, but some of these residues are not 
located in the same position in the amino acid se- 
quence. Thus, comparison of the results obtained 
with these 2 proteins may lead to a better 
understanding of the contribution of lysine 
residues to their biological activity. Only chemical 
modifications preserving the basicity of the group 
(methylation, ethylation, guanidination and 
acetimidination) were performed, since the aboli- 
tion of positive charges can cause secondary effects 
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on the conformation of the protein. The biological 
activity was investigated using a radioligand recep- 
tor assay with rabbit mammary homogenates. 
2. MATERIALS AND METHODS 
at pH 10.3 and 5°C. hGH was treated under the 
same conditions but at a much lower concentration 
of reagent (0.01 M) to obtain a small degree of 
chemical modification. Determination of the c- 
acetimidyllysine was performed by amino acid 
analysis as in [7]. 
2.1. ~~e~ica~ modifications 
Ovine prolactin was a purified preparation kind- 
ly provided by NIH (NIH PS7: 24 IU/mg). 
Human growth hormone (1 IU/mg) was a gift 
from Drs Dray and Groh (Institute Pasteur, Paris). 
2.1.1. Reductive alkylation 
Reductive methylation and ethylation were car- 
ried out by addition of sodium borohydride and 
formaldehyde or acetaldehyde to the hormones 
(0.5-1.0 mg) dissolved in borate buffer (pH 9) as 
in [5]. The solutions were diafyzed against a 
pyridine solution (1 To) and freeze-dried. Deter- 
minations of lysine, and methyl- and ethyllysine 
were made using a Technicon autoanalyzer and 
elution gradients containing isopropanol [5,6]. A 
blank for biological assays was prepared by 
treating hormone with borohydride and borate 
buffer (pH 9, no added aldehyde). In the case of 
ovine prolactin whose disulfide bridges are par- 
ticularly labile to the reductive action of 
borohydride (BHZ), the reductive alkylation was 
performed at a lower concentration of BHI 
(20 mM) for a shorter period (30 min) and in the 
presence of iodoacetamide (40 mM) to block the 
SH groups, avoiding the disordered reconstitution 
of disulfide bonds. 
2.1.2. Guanidination 
This reaction was performed using 0.3 M O- 
methylisourea sulfate (Aldrich, France) at pH 10.3 
and 5°C (0.7 mg hormone/O.15 ml) for 24 h. At 
the end of the reaction, the solutions were dialyzed 
against pyridine solutions. After 1 day of reaction, 
the solution became slightly opalescent. In both 
cases, the solutions were centrifuged and the 
precipitate discarded. The degree of guanidination 
was measured by amino acid analysis. A control 
was prepared by treatment of the hormone at pH 
10.4 for 1 day at 5°C. 
2.1.3. Acetimidination 
Prolactin (0.7 mg10.5 ml) was treated with 1 M 
ethylacetimidate hydrochloride (Aldrich) for 24 h 
2.2. Radioreceptor assay of lactogenic activity 
This activity was measured as in [S]. Mammary 
gland membranes were obtained from rabbits 
treated on day 10 of lactation with 2_cu- 
bromocryptine (CB 154, Sandoz, 2 mg twice daily 
for 2 days) to desaturate their receptors. The stan- 
dard curve was established by incubation of mem- 
brane receptors, radioiodinated prolactin and dif- 
ferent concentrations of unlabelled ovine prolactin 
(NIH PS7, 24 IU/mg) for 5 h at 21°C. Lactogenic 
activity of modified hormones was determined by 
adding these hormone derivatives to the incubation 
medium instead of the unlabelled prolactin. The 
specificity of the assay was checked: only hor- 
mones with lactogenic activity in the rabbit (pro- 
lactins of different species, placental actogens and 
human growth hormone) are able to compete with 
ovine prolactin at the rabbit mammary receptor 
sites. The rabbit receptor exhibits less strict 
specificity than the ovine receptor. 
3. RESULTS AND DISCUSSION 
The percentage of modified lysine residues 
determined by amino acid analysis is reported in 
table 1. In both methyl- and ethyllysine, the 
positive charge is preserved almost without change 
of the pKor of its position in relation with the pep- 
tidic backbone. However, the ethyl chain is longer 
than the methyl one and therefore greater steric 
hindrance may occur in binding to the receptors. 
Nevertheless, the degree of ethylation was lower in 
the proteins studied and the more disturbing action 
of the ethyl group can be compensated by a lower 
degree of modification. 
The degree of guanidination was similar to that 
of methylation. The degree of acetimidination was 
much higher in the case of ovine prolactin because 
of the more drastic reaction conditions. 
Reductive alkylation was performed in the 
presence of BHZ which can affect some very labile 
disulfide bonds. Ovine prolactin subjected to BH6 
at pH 9 lost about 70% of its biological activity 
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Degree of modification of lysine residues and binding capacity of modified oPRL and hGH to lactogenic receptors 
Modified BK, pH 9 Methylated Ethylated pH 10 (control) Guanidinated Acetimidinated 
hormones (control) 
D.M. L.A. D.M. L.A. D.M. L.A. D.M. L.A. D.M. L.A. D.M. L.A. 
oPRL 0 90a 80 24 45 73 0 100 66 21 80 20 
hGH 0 90 14 41 52 15 0 100 52 67 10-20 100 
a Reductive alkylation was performed in the presence of iodoacetamide 
D.M., degree of chemical modification of the lysine residues expressed as a percentage; L.A., lactogenic activity 
expressed as a percentage of the binding activity of native hormone calculated by comparison of the hormone 
concentration needed for 50% inhibition of specific binding 
(fig.1). When iodoacetamide was added im- 
mediately after the reduction treatment, the loss of 
activity was still considerable. However, when us- 
ing the treatment in the presence of iodoacetamide, 
most of the activity of oPRL was preserved (fig.1 
and table 1). Amino acid analysis showed in the 
latter case the presence of carboxymethylcysteine 
(0.5 residue per molecule) suggesting that 
reconstitution of disulfide bonds was prevented by 
blocking the -SH groups. A decrease in the lac- 
togenic activity of oCS was also observed after 
treatment with BH4 without iodoacetamide [4] 
I 
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Fig. 1. Specific binding of native and modified oPRL in 
a radioreceptor assay for lactogenic activity with 
lactating rabbit mammary membranes. (&--A) Native 
oPRL; (a) Red-oPRL: reduced oPRL (treated with 
BH; without iodoacetamide); (@--@) Red-oPRL bis: 
reduced oPRL (treated with B& in the presence of 
iodoacetamide); (M) Met-oPRL: methylated oPRL; 
(M) Et-oPRL: ethylated oPRL; (M) Gu-oPRL: 
guanidinated oPRL; (H) Am-oPRL: acetimidylated 
oPRL. 
which probably could be avoided by adding this 
reagent. 
As seen in table 1 and figs 2,3, ethylation only 
slightlyaffected the lactogenic activity of both hor- 
mones (oPRL, hGH) but the degree of modifica- 
tion was smaller than in the case of methylation. 
The loss of activity was significant in the 
methylated hormones. Decreased activity was also 
observed in the case of the guanidyl derivatives. 
The fact that guanidyl oPRL exhibited a much 
lower lactogenic activity could be explained by the 
modification of some lysine residues correspon- 
ding to arginine residues in the hGH molecule 
(such as Lys 146 and Lys 193, see fig.3) where the 
sequences of oPRL and hGH are reproduced as 
reported in [2,9]. 
The results reported above suggest that some 
lysine residues of hormone molecules are involved 
in the interaction between oPRL or hGH and their 
lactogenic receptors even though the repercussion 
of their chemical modification on biological activi- 
ty was less drastic than in the case of 
somatotropins [lo]. Some lysine residues were par- 
ticularly well preserved during evolution: Lys 128 
and 187 are common to all prolactins (in rat, pig, 
sheep, cattle and man), hCS, the only placental 
lactogen whose primary sequence was reported and 
all known growth hormones (in rat, pig, horse, 
sheep, cattle and man) (fig.3) [2,3,9,11-171. Lys 
42 and 5 1 of oPRL could correspond approximate- 
ly in hGH sequence to the positions of Lys 47 and 
50, which could occupy a similar place in the steric 
conformation of the molecule when the gaps are 
excluded. Lys 42 and 5 1 of oPRL were very conser- 
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Fig.2. Specific binding of native and modified hGH in a 
radioreceptor assay for iactogenic activity with lactating 
rabbit mammary membranes. (ti) Native hGH; 
(s) Red-hGH: reduced hGH (treated with BH; 
without iodoacetamide); (o--u)Met-hGH: methylated 
hGH; (C--o) Et-hGH: ethylated hGH; (+---o) Gu- 
hGH: guanidinated hGH; (H) Am-hGH: 
acetimidylated hGH. 
vative during evolution. Although rat prolactin 
showed a very high rate of evolution (58.7 accepted 
point mutations/l00 residues per 10’ years) in 
comparison with other prolactin molecules [ 181, 
residues 42 and 51 of rat PRL are arginine. 
Residue 50 of hGH was preserved in hCS and all 
known growth hormones but Lys 47 of hGH and 
hCS was substituted by a glutamic acid in bovine, 
ovine, equine, rat GH. These latter hormones are 
not lactogenic. 
Other prolactin lysines (73, 146, 193) are 
substituted by arginines in hGH (positions 73, 147 
and 193 in fig.3). However, Arg 183 of oPRL is 
replaced by Lys in hGH. Thus these conservative 
amino acid residues could play a role in the binding 
to lactogenic receptors. At the present ime, we can 
add that enzymatic rupture by plasmin of the pep- 
tide bond between Met 53 and Ala 54 of oPRL 
(positions 56 and 57 in our scheme because of 
gaps, fig.3) destroys the biological activity [19]. 
These results suggest hat the N-terminal segment 
of the oPRL molecule has a significance for lac- 
togenic activity and that the lysines located in this 
part of the sequence should be involved in the in- 
teraction with the receptors. Partial lactogenic ac- 
tivity was also exhibited by fragments 1-134 of 
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Fig.3. Comparison of oPRL and hGH primary 
sequences oPRL and hGH. (-m-) Amino acid; ( ) gap; 
L, lysine; (0) amino acid in the hGH sequence different 
from oPRL sequence; (0) position occupied by a lysine 
residue in all known prolactins, growth hormones and 
human placental actogen; (1) enzymatic rupture of hGH 
by trypsin; (S) enzymatic rupture of oPRL by plasmin. 
hGH [20,21] corresponding to 1-147 in fig.3. In 
contrast, lactogenic activity was preserved after 
selective removal with trypsin of residues 135-145 
of hGH suggesting that Lys 153 and 158 are not 
implicated in the function [22]. Other lysine 
residues were not preserved during evolution and 
not substituted by a basic amino acid residue, i.e. 
lysines in position 110 of the oPRL molecule or in 
position 172 of the hGH molecule (fig.3). To sum- 
marize, amino acid residues of oPRL in positions 
42, 51, 73, 128, 146 and 47, 50, 73, 128, 147 of 
hGH might be particularly involved in the binding 
to lactogenic receptors. Further studies will be re- 
quired to locate and define precisely the contribu- 
tion of these lysines to the Iactogenic activity. 
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